Predicted to enable 3-oxo-5-alpha-steroid 4-dehydrogenase activity. Predicted to be involved in dolichol-linked oligosaccharide biosynthetic process. Is an ortholog of C. elegans B0024.13.
Predicted to enable 3-oxo-5-alpha-steroid 4-dehydrogenase activity. Predicted to be involved in steroid metabolic process. Predicted to be located in membrane. Is an ortholog of C. elegans ZK1251.3.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in cellular aldehyde metabolic process. Is an ortholog of C. elegans alh-4.
Predicted to enable 3-oxo-5-alpha-steroid 4-dehydrogenase activity. Predicted to be involved in steroid metabolic process. Predicted to be located in membrane. Is an ortholog of C. elegans F42F12.3. In C. elegans, F42F12.3 is involved in innate immune response.
Predicted to enable NAD binding activity; NADP binding activity; and oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in glucose metabolic process. Is an ortholog of C. elegans gpd-1 and gpd-4.
Predicted to enable NAD binding activity; NADP binding activity; and oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in glucose metabolic process. Is an ortholog of C. elegans gpd-1 and gpd-4.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor. Is an ortholog of C. elegans bckd-1A.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor. Is an ortholog of C. elegans bckd-1A.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-7.